Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Supports cardiac surveillance in doxorubicin recipients; leaves open optimal long-term prevention strategies.
Yamashita et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: